JAGX — Jaguar Health, Inc.
$0.42
+$0.02 (+4.73%)
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health.
Market Cap
$5.59M
Forward P/E
-0.1x
52-Week Range
N/A
JAGX Price History
Revenue vs. Net Income
$11.5M
Revenue · FY2025
Annual. Net margin is shown under each year.
Free Cash Flow
-$23.7M
FCF · FY2025
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
-203.6%
ROCE · FY2025 (approx.)
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
0.7x
Assets ÷ liabilities · FY2025
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
0.4%
CapEx · FY2025
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
+691.9%
Dilution · FY2025
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
